JPRN-UMIN000042226
Recruiting
未知
Prospective observational study of the efficacy and safety of carbon-ion radiotherapy followed by Nivolumab for primary mucosal malignant melanoma of the head and neck - iROCK-2001H
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization0 sites34 target enrollmentOctober 26, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- mucosal malignant melanoma of the head and neck
- Sponsor
- Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
- Enrollment
- 34
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients with interstitial pneumonia, drug\-induced interstitial lung disease or clinically active interstitial lung disease on chest CT scan 2\)Patients with autoimmune disorders 3\)Known allergy to compounds of similar chemical or biologic composition to Nivolumab 4\)Pregnant or lactating females 5\)Patients in which the physician decides that participation in the study is unsuitable
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective observational study on the efficacy and safety of EPA in advanced gastric cancer patients treated by S-1+CDDP as first line.gastric cancerJPRN-UMIN000016226Kyushu medical center, medical oncology30
Not yet recruiting
Not Applicable
Study on the efficacy and safety of Hydra valveHealth Condition 1: I350- Nonrheumatic aortic (valve) stenosisCTRI/2024/05/067666Sahajanand Medical Technologies Limited (SMT)
Recruiting
Not Applicable
A prospective observational study on the efficacy of switching to sertraline in depressive patients who failed treatment with duloxetinemajor depressive disorderJPRN-UMIN000009609Tokyo Womens Medical University100
Not yet recruiting
Not Applicable
Study of effectiveness and side effects of light therapy with oral medication called Khellin in Vitiligo patients.CTRI/2020/02/023495Dr Lavin Bhatia
Recruiting
Not Applicable
The efficacy and safety of the Gefapixant in patients with interstitial lung diseaseinterstitial lung diseaseJPRN-jRCT1031220275Abe Mitsuhiro30